What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Gene
His scientific interests lie mostly in Internal medicine, Endocrinology, Thyroid, Graves' ophthalmopathy and Graves' disease.
His Gastroenterology research extends to Internal medicine, which is thematically connected.
The Endocrinology study combines topics in areas such as Randomized controlled trial and Risk factor.
His Thyroid study combines topics from a wide range of disciplines, such as Odds ratio and Pediatrics.
The study incorporates disciplines such as Physical therapy and Surgery in addition to Graves' ophthalmopathy.
His Graves' disease research includes themes of SNP, Single-nucleotide polymorphism, Prospective cohort study and MEDLINE.
His most cited work include:
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium (1609 citations)
- Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy (817 citations)
- Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy (586 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Endocrinology, Thyroid, Graves' ophthalmopathy and Graves' disease.
His Internal medicine study combines topics in areas such as Gastroenterology and Immunology.
His Endocrinology research is multidisciplinary, incorporating elements of Receptor and Amiodarone.
His Thyroid study frequently links to related topics such as Pediatrics.
In his research, Optic neuropathy is intimately related to Surgery, which falls under the overarching field of Graves' ophthalmopathy.
His studies in Graves' disease integrate themes in fields like Autoimmune disease and Immunopathology.
He most often published in these fields:
- Internal medicine (64.65%)
- Endocrinology (58.60%)
- Thyroid (26.75%)
What were the highlights of his more recent work (between 2012-2020)?
- Internal medicine (64.65%)
- Endocrinology (58.60%)
- Thyroid (26.75%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Thyroid, Euthyroid and Pediatrics.
His study in the field of Randomized controlled trial, Disease and Graves' ophthalmopathy is also linked to topics like In patient.
His work deals with themes such as Methylprednisolone and Referral, which intersect with Graves' ophthalmopathy.
His study on Thyroiditis is often connected to Context as part of broader study in Endocrinology.
His work in Euthyroid tackles topics such as Combination therapy which are related to areas like Thyroid function tests.
Wilmar M. Wiersinga interconnects Surgery, Myxedema coma, Epidemiology and Quality of life in the investigation of issues within Pediatrics.
Between 2012 and 2020, his most popular works were:
- The 2016 European Thyroid Association/European Group on Graves' orbitopathy guidelines for the management of graves' orbitopathy (379 citations)
- Smoking and thyroid. (181 citations)
- MECHANISMS IN ENDOCRINOLOGY: Autoimmune thyroid disease: old and new players (149 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Surgery
Wilmar M. Wiersinga mainly investigates Internal medicine, Endocrinology, Thyroid, Pediatrics and Graves' ophthalmopathy.
Wilmar M. Wiersinga has included themes like Ex vivo, Placebo and Immunology in his Internal medicine study.
His research integrates issues of Vitamin D and neurology and Graves' disease in his study of Immunology.
He conducted interdisciplinary study in his works that combined Endocrinology and Context.
His research in Thyroid is mostly concerned with Thyroid peroxidase.
The concepts of his Pediatrics study are interwoven with issues in Myxedema coma, Quality of life, Epidemiology and Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
